Accendra Health layoffs, on the record
Every job cut, severance charge and restructuring Accendra Health reported in its annual reports, 2023 to 2025, quoted from the filings.
Headcount, as reported
| Annual report | Employees | As of |
|---|---|---|
| 10-K for 2023 | approximately 13,700 full-time and part-time teammates in the U.S. and 8,500 teammates outside of the U.S | At the end of 2023 |
| 10-K for 2024 | approximately 13,500 full-time and part-time teammates in the U.S. and 9,700 teammates outside of the U.S | At the end of 2024 |
| 10-K for 2025 | over 6,500 | At the end of 2025 |
Job cuts, severance and restructuring
Our summaryCompany recorded exit and realignment charges, mainly tied to its Operating Model Realignment Program, which includes severance and other costs to streamline functions.
Word for word“Exit and realignment charges were $99.1 million and $6.9 million for the years ended December 31, 2023 and 2022.” 10-K for 2023
Our summaryCompany recorded severance and related restructuring accrual activity during 2023.
Word for word“Provision for exit and realignment activities: Severance 11,556 Professional fees 63,699 Vendor contract and lease termination costs 6,198 IT strategic initiatives 8,649 Other 5,619 Cash payments ( 76,643 ) Accrued exit and realignment charges, December 31, 2023 $ 20,047” 10-K for 2023
Our summaryCompany reorganized the Products & Healthcare Services segment with severance and other charges, and wound down Fusion5.
Word for word“Amounts in 2022 consisted primarily of severance and other charges associated with the reorganization of the Products & Healthcare Services segment and wind-down costs related to Fusion5.” 10-K for 2023
Our summaryCompany reported exit and realignment charges tied to its 2023-2024 Operating Model Realignment Program, which includes severance to streamline functions and processes.
Word for word“Exit and realignment charges, net were $110 million and $99 million for the years ended December 31, 2024 and 2023.” 10-K for 2024
Our summaryCompany recorded severance and other costs under its exit and realignment accrual activity during 2024.
Word for word“Accrued exit and realignment charges, December 31, 2024 $ 14,099 In addition to the exit and realignment accruals in the preceding table and the $ 7.4 million gain associated with the sale of our corporate headquarters, we also incurred $ 15 million of costs that were expensed as incurred for the year ended December 31, 2024, which primarily related to accelerated depreciation of certain assets held in our Products & Healthcare Services segment.” 10-K for 2024
Our summaryCompany recorded 2023 exit and realignment charges that included severance under the 2023-2024 Operating Model Realignment Program.
Word for word“Amounts in 2023 were primarily related to our (1) 2023-2024 Operating Model Realignment Program of $82.9 million, including professional fees, severance, and other costs to streamline functions and processes, (2) IT strategic initiatives such as converting certain divisions to a common IT system of $9.2 million and, (3) other costs associated with strategic initiatives of $7.0 million, including lease exit costs.” 10-K for 2024
Our summaryThe company recorded net exit and realignment charges for 2025, including severance for strategic realignments, wind-down costs of Fusion5, and professional fees.
Word for word“Exit and realignment charges, net were $18 million for the year ended December 31, 2025.” 10-K for 2025
Our summaryThe company reported severance costs tied to strategic realignments as part of its 2025 exit and realignment charges.
Word for word“These charges included professional fees associated with strategic initiatives of $8.4 million, $6.8 million related to wind-down costs of Fusion5, severance associated with strategic realignments of $5.4 million, a $4.8 million gain on sale of patient service equipment in response to the contract termination with a commercial Payor and IT strategic initiatives and other of $1.5 million.” 10-K for 2025
Our summaryThe company recorded net exit and realignment charges for 2024, made up of professional fees for strategic initiatives and IT strategic initiatives.
Word for word“Exit and realignment charges, net were $47 million for the year ended December 31, 2024 which included professional fees associated with strategic initiatives of $36 million and IT strategic initiatives and other of $11 million.” 10-K for 2025
| Fiscal year ended | Restructuring charges | Restructuring costs incurred | Cash paid for restructuring |
|---|---|---|---|
| 2016-12-31 | $11.8 million | $11.9 million | $11.7 million |
| 2017-12-31 | $17.7 million | $26.1 million | $7.6 million |
| 2018-12-31 | $10.3 million | $6.7 million | $14 million |
| 2019-12-31 | — | — | $13.7 million |
| 2020-12-31 | — | $10.6 million | $20.3 million |
| 2021-12-31 | — | $11.2 million | $14.8 million |
| 2022-12-31 | — | $700,000 | $13.5 million |
| 2023-12-31 | — | — | $4.5 million |
| 2024-12-31 | — | — | $43.2 million |
| 2025-12-31 | — | — | $17.3 million |
Accendra Health filed 2 restructuring notices (Form 8-K, Item 2.05) since 2016. This page shows what the company reported to the SEC, not news reports or state layoff notices.
Read from Accendra Health’s annual reports (10-K for 2025, 10-K for 2024, 10-K for 2023) and the financial data it files with the SEC, as of 2026-02-20. Every quotation is word for word from the filing linked beside it; how these pages are built and checked. The full record is in its company data sheet.